Organogenesis Holdings (ORGO) Gains from Investment Securities (2018 - 2021)
Organogenesis Holdings' (ORGO) quarterly Gains from Investment Securities came in at -$927000.0 in Q3 2021, up 66.44% quarter-over-quarter from -$2.8 million in Q2 2021.
Organogenesis Holdings (ORGO) Gains from Investment Securities (2018 - 2021) Analysis & Trends
Organogenesis Holdings' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at -$927000.0 for Q3 2021.
- On a quarterly basis, Gains from Investment Securities changed N/A year-over-year to -$927000.0 in Q3 2021; TTM through Jun 2022 was -$927000.0, a 67.34% increase from a year earlier, with the FY2021 full-year figure at -$4.0 million, down 2063.05% from the prior year.
- Gains from Investment Securities grew to -$927000.0 in Q3 2021 per ORGO's latest filing, from -$2.8 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $176000.0 in Q2 2018 and bottomed at -$2.8 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Organogenesis Holdings | 323.97 Mn | 231.87 Mn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -927,000.00 |
| Sep 30, 2021 | -927,000.00 |
| Jun 30, 2021 | -2.76 Mn |
| Jun 30, 2021 | -2.76 Mn |
| Mar 31, 2021 | -296,000.00 |
| Mar 31, 2021 | -296,000.00 |
| Dec 31, 2018 | 170,000.00 |
| Dec 31, 2018 | 170,000.00 |
| Sep 30, 2018 | 50,000.00 |
| Sep 30, 2018 | 50,000.00 |
| Jun 30, 2018 | 176,000.00 |
| Jun 30, 2018 | 176,000.00 |
| Mar 31, 2018 | 73,000.00 |
| Mar 31, 2018 | 73,000.00 |